pandem
influenza
major
caus
health
burden
gain
worldwid
attent
scientist
better
diagnosi
treatment
one
import
caus
acut
respiratori
infect
caus
diseas
age
group
howev
infect
rate
higher
among
infant
also
account
complic
like
pneumonia
viremia
myositi
myocardi
dysfunct
spread
countri
develop
countri
compar
risk
lack
hygien
overpopul
poverti
scarciti
modern
tool
diagnosi
treatment
influenza
viru
known
continu
antigen
chang
antigen
drift
properti
viru
signific
effect
prevent
vaccin
diagnosi
treatment
although
emerg
new
strain
viru
stop
spread
origin
might
limit
prevent
countri
countri
transmiss
report
case
endem
occur
england
incountri
pandem
sever
acut
respiratori
syndrom
last
decad
clear
rapid
identif
proper
surveil
tremend
help
respond
outbreak
short
time
provid
secur
global
public
health
one
major
prevent
circul
strain
influenza
viru
complic
associ
viral
infect
vaccin
viru
season
vaccin
need
prepar
accord
predict
certain
strain
would
circul
particular
also
antivir
agent
influenza
found
effect
use
earli
cours
ill
four
drug
avail
influenza
viru
amantadin
rimantidin
zanamivir
studi
report
resist
pattern
viru
amantadin
rapid
detect
resist
clinic
import
reduc
time
diagnosi
initi
individu
therapi
therefor
close
monitor
preval
antivir
resist
discoveri
drug
potent
vaccin
necessari
control
influenza
burden
anoth
import
aspect
control
influenza
burden
earli
diagnosi
howev
diagnosi
physician
difficult
mani
respiratori
virus
produc
similar
symptom
like
influenza
therefor
clinic
laboratori
diagnosi
mandatori
correct
earli
diagnosi
although
sever
test
develop
detect
influenza
virus
differ
sensit
specif
throughput
cost
avail
factor
involv
preanalyt
postanalyt
stage
clinic
laboratori
test
factor
play
crucial
role
select
diagnost
test
method
clinic
laboratori
use
highli
sensit
specif
test
yield
accur
result
rel
short
time
benefici
patient
reduc
advers
effect
complic
use
appropri
drug
antivir
therapi
influenza
detect
nasopharyng
np
swab
np
aspir
best
choic
collect
aspir
small
amount
steril
salin
appli
nose
suction
collect
result
fluid
salin
mucu
sampl
put
special
contain
preserv
organ
deliveri
np
swab
collect
insert
dacron
swab
one
nostril
resist
met
inch
rotat
sever
time
withdrawn
doctor
usual
use
np
swab
adult
nasal
wash
aspir
child
situat
doctor
may
use
throat
swab
contain
less
viru
np
aspir
therefor
may
suitabl
use
rapid
test
antibodi
test
blood
sampl
furthermor
sampl
long
storag
repeat
freez
thaw
found
degrad
viral
rna
cdna
sampl
low
viral
copi
degrad
may
limit
quantit
polymeras
chain
reaction
pcr
howev
sampl
high
viral
titr
limit
quantit
sever
freez
thaw
cycl
antibodi
produc
onset
influenza
viru
ill
detect
use
serolog
diagnost
techniqu
like
hemagglutin
inhibit
assay
hia
enzym
immunoassay
eia
complement
fixat
neutral
one
studi
report
antibodi
titer
reach
peak
within
day
ill
found
revers
transcript
polymeras
chain
reaction
rtpcr
posit
influenza
viru
seroconvert
use
hia
viru
micro
neutral
hia
found
use
prohibit
vaccin
likelihood
sever
reaction
next
outbreak
howev
method
regard
effect
diagnost
tool
conveni
method
requir
two
serum
sampl
accur
time
also
longer
therefor
center
diseas
control
prevent
cdc
recommend
techniqu
diagnosi
purpos
addit
test
result
interpret
possibl
misguid
clinic
decis
although
viral
cultur
time
cosum
major
techniqu
detect
influenza
viru
mani
instanc
monkey
kidney
cell
madin
darbi
canin
kidney
mdck
cell
cell
use
detect
influenza
virus
inocul
virus
caus
cytopatholog
differ
accord
cell
type
use
take
around
day
get
result
delay
initi
antivir
therapi
infect
control
human
respiratori
epitheli
cell
also
known
enhanc
growth
influenza
shell
vial
cultur
svc
method
introduc
combin
svc
certain
monoclon
antibodi
found
decreas
turnaround
time
along
increas
sensit
hand
commerci
rmix
cell
diagnost
hybrid
athen
oh
usa
found
sensit
cell
cultur
techniqu
cell
mixtur
contain
mink
lung
epitheli
cell
cell
use
cell
mixtur
give
result
h
rmix
anoth
cell
mixtur
mdck
cell
detect
respiratori
virus
amplifi
replic
order
identifi
specif
kit
name
ultra
influenza
id
kit
id
kit
diagnost
hybrid
inc
athen
oh
usa
develop
util
rmix
cell
method
use
immunofluoresc
method
specif
diagnosi
although
viral
cultur
method
detect
influenza
viru
adopt
mani
clinic
set
newli
avail
rapid
test
pcrbase
test
gain
popular
fast
detect
abil
compar
sensit
specif
rapid
test
known
sensit
comparison
viral
cultur
method
pcrbase
one
studi
reveal
similar
sensit
specif
rapid
antigen
test
viral
cultur
techniqu
howev
pcrbase
assay
sensit
specif
specif
rapid
test
found
rapid
test
result
depend
viral
titer
sampl
lowest
viru
titer
process
pcrbase
assay
importantli
pcr
techniqu
found
yield
high
sensit
specif
adult
low
titr
virus
everi
patient
clinician
wish
know
causat
diseas
earli
possibl
ill
begin
meet
aim
rapid
test
detect
influenza
viru
evolv
past
decad
sever
test
develop
use
rapid
test
found
flourish
day
day
true
abil
provid
test
result
within
half
hour
easi
interpret
although
test
abl
gain
trustworthi
sever
limit
like
frequent
fals
posit
fals
neg
known
yield
better
result
sampl
higher
titer
children
adult
especi
develop
countri
pcr
techniqu
avail
primari
health
care
set
aid
clinic
decis
make
found
use
sole
diagnost
purpos
test
handi
also
known
near
patient
point
care
test
method
today
focu
rapid
identif
influenza
center
increas
sensit
specif
test
potenti
use
earli
accur
diagnosi
influenza
commerci
avail
rapid
antigen
test
mostli
immunoassay
target
antigen
influenza
viru
howev
rel
poor
sensit
comparison
viru
cultur
techniqu
pcrbase
assay
one
studi
use
quickvu
influenza
ab
quidel
refer
rtpcr
found
sensit
specif
detect
respect
suggest
use
rtpcr
clinic
studi
howev
found
sensit
comparison
anoth
studi
use
two
rapid
antigen
test
bd
directigen
ez
flu
truflu
meridian
got
better
perform
former
kit
later
one
sensit
specif
detect
bd
directigen
ez
flu
wherea
truflu
meridian
tsao
et
recent
analyz
four
rapid
test
name
binaxnow
test
quickvu
test
tru
test
formosa
rapid
test
found
detect
limit
lower
rtpcr
nevertheless
found
sensit
formosa
rapid
test
similar
quickvu
test
rel
sensit
kit
diagnosi
furthermor
anoth
studi
use
sd
biolin
influenza
antigen
kit
found
poor
perform
sensit
specif
respect
contrast
recent
studi
reveal
sensit
actim
influenza
b
kit
medix
biochemica
joensuu
finland
detect
influenza
viru
among
year
old
test
perform
quickvu
influenza
test
month
year
children
show
sensit
specif
influenza
indic
pediatr
group
gener
higher
viral
load
fair
enough
kit
detect
viru
comparison
adult
patient
next
import
thing
rapid
kit
sensit
specif
comparison
pcrbase
assay
direct
fluoresc
antibodi
assay
dfa
confer
cheap
fast
result
although
sensit
pcr
test
sever
studi
perform
especi
surveil
one
sole
base
dfa
techniqu
involv
stain
cell
sampl
follow
bioconjug
antibodi
fluoresc
dye
time
frame
obtain
result
sensit
dfa
test
influenza
viru
found
similarli
specif
rang
indic
sensit
compar
higher
rapid
antigen
detect
kit
lower
pcr
test
mean
neg
result
need
confirm
pcrbase
assay
although
studi
recommend
use
dfa
well
svc
togeth
increas
sensit
test
dfa
alon
multipl
viru
infect
rule
recent
studi
shown
particularli
sensit
specif
dfa
respect
compar
rtpcr
variabl
age
perform
test
better
children
year
age
wherea
sensit
test
decreas
person
year
contrast
sensit
dfa
adult
studi
pollock
et
anoth
studi
sensit
dfa
shown
lower
comparison
rtpcr
similarli
studi
compar
dfa
rapid
antigen
test
rtpcr
show
former
two
test
compar
low
sensit
respect
comparison
rtpcr
suggest
confirmatori
test
rtpcr
howev
dfa
test
requir
skill
expertis
fluoresc
microscopi
furthermor
dfa
test
carri
shift
basi
gener
clinic
set
prolong
turnaround
time
thu
seem
suitabl
test
regard
clinic
laboratori
diagnosi
influenza
viru
comparison
pcr
base
assay
number
studi
report
pcrbase
assay
overcom
sever
demerit
possess
techniqu
rapid
influenza
detect
test
ridt
svc
respect
sensit
specif
time
qualit
quantit
approach
diagnosi
rtpcr
regard
king
diagnosi
virus
includ
influenza
viru
type
rtpcr
one
step
rtpcr
involv
use
oligodt
random
primer
revers
transcript
next
two
step
rtpcr
revers
transcript
perform
pcr
carri
briefli
rna
extract
influenza
sampl
purifi
transcrib
use
oligonucleotid
specif
target
sequenc
produc
first
pcrbase
assay
detect
influenza
viru
describ
zhang
sinc
mani
modif
highli
sensit
method
base
pcr
develop
instanc
pcrenzym
immunoassay
found
better
perform
cultur
method
case
day
similarli
rtpcr
follow
electrospray
ioniz
mass
spectrometri
abl
detect
cultureunidentifi
outbreak
occur
cdc
recommend
use
one
step
rtpcr
techniqu
target
matrix
gene
type
subtyp
specif
detect
methodolog
use
techniqu
alreadi
describ
use
hemagglutinin
gene
target
singl
tube
minim
cost
time
requir
analyz
sampl
type
subtyp
influenza
pcrbase
assay
resplex
ii
qiagen
hilden
germani
multicod
plx
rvp
eragen
bioscienc
madison
wi
usa
seeplex
rv
seegen
inc
seoul
korea
ngen
rva
asr
nanogen
inc
san
diego
ca
usa
xtag
rvp
luminex
molecular
diagnost
toronto
ontario
canada
proflu
prodess
inc
san
diego
ca
usa
prodess
inc
san
diego
ca
usa
also
among
later
three
approv
food
drug
administr
fda
detect
respiratori
virus
includ
influenza
virus
multiplex
rtpcr
techniqu
highli
sensit
specif
give
result
compar
less
time
viral
cultur
eia
techniqu
consid
differ
pcrbase
assay
techniqu
ridt
svc
aspect
merit
diagnosi
influenza
viru
pcr
method
seem
effect
howev
intens
research
medic
diagnosi
led
even
effect
diagnost
tool
base
pcr
assay
instanc
nucleic
acid
sequencebas
amplif
test
known
sensit
rtpcr
test
detect
influenza
viru
techniqu
three
enzym
use
name
amvrt
rna
polymeras
rnaseh
detect
min
sensit
specif
moreov
multiplex
nucleic
acidbas
amplif
test
along
enzymelink
oligonucleotid
captur
shown
rapidli
specif
detect
singl
viru
includ
influenza
virus
b
multiplex
group
reduc
laboratori
test
time
enabl
high
throughput
although
nucleic
acidbas
amplif
assay
found
yield
better
sensit
comparison
method
techniqu
studi
fda
instanc
respiratori
viru
plu
nucleic
acid
test
rv
nanospher
chicago
il
usa
recent
clear
fda
autom
method
diagnosi
sensit
specif
accordingli
cepheid
compani
sunnyval
ca
usa
develop
flu
influenza
viru
panel
test
fdaclear
fulli
autom
techniqu
detect
knowledg
genet
basi
resist
drug
provid
molecular
techniqu
quickli
detect
mutat
confer
resist
drug
instanc
one
wide
use
drug
influenza
infect
oseltamivir
resist
aris
due
histidin
tyrosin
substitut
neuraminidas
activ
site
techniqu
avail
monitor
drug
resist
includ
neuraminidas
inhibit
assay
pyrosequenc
use
genotyp
specif
primer
real
time
known
time
consum
sequenc
method
pyrosequenc
provid
detail
genet
inform
resist
pattern
also
estim
rel
proport
variant
wildtyp
virus
mix
popul
sampl
appli
directli
clinic
howev
need
addit
step
initi
pcr
special
person
oper
sequenc
instrument
realtim
quantit
rtpcr
provid
rapid
highli
sensit
specif
altern
howev
either
specif
season
influenza
need
multipl
primer
detect
rtpcr
combin
pyrogram
techniqu
provid
detect
sequenc
within
h
sensit
similar
pyrosequenc
method
season
similarli
cycl
probe
realtim
pcr
assay
shown
provid
test
result
within
h
receiv
sampl
resist
oseltamivir
also
abl
detect
season
well
virus
resist
howev
major
drawback
new
set
primer
probe
develop
event
novel
drugresist
strain
would
emerg
influenza
viru
signific
global
health
burden
time
diagnosi
initi
treatment
reduc
stigma
diseas
also
help
outbreak
control
sole
interpret
clinician
base
symptom
present
patient
specif
viru
symptom
common
known
respiratori
virus
therefor
clinician
alway
need
confirmatori
test
influenza
infect
soon
ill
initi
cultur
method
timeconsum
sensit
specif
make
clinician
start
antivir
therapi
howev
still
use
mani
laboratori
suggest
influenza
diagnosi
cultur
method
need
substanti
qualiti
check
continu
monitor
increas
qualiti
report
fast
specif
ridt
also
call
point
care
test
also
appropri
diagnosi
influenza
viru
poor
perform
howev
simpl
cheap
easili
interpret
handi
show
similar
better
perform
pcrbase
assay
would
major
techniqu
detect
influenza
viru
howev
need
studi
well
improv
extent
use
accur
specif
diagnosi
viru
recent
advanc
pcrbase
assay
becom
popular
advanc
countri
howev
deni
fact
popular
model
also
sever
limit
rang
nucleic
acid
extract
result
interpret
even
neglig
amount
error
potenti
effect
result
interpret
highli
sensit
test
therefor
also
higher
possibl
yield
fals
posit
result
comparison
viral
cultur
method
thu
valid
reagent
applic
proper
posit
neg
control
use
autom
could
reduc
chanc
error
molecular
diagnosi
influenza
infect
hand
cell
cultur
method
ridt
undergo
standard
qualiti
assur
qualiti
control
measur
order
valid
result
henc
studi
need
valid
interpret
influenza
viru
diagnost
techniqu
besid
mani
merit
demerit
pcr
basedassay
far
suggest
techniqu
diagnosi
influenza
viru
therefor
clinician
reli
rtpcr
test
result
patient
correl
clinic
aspect
patient
